Vitamin Shoppe, Inc (NYSE:VSI) shares gapped down before the market opened on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $3.59, but opened at $3.45. Vitamin Shoppe shares last traded at $3.50, with a volume of 278887 shares traded.

The specialty retailer reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 20.27% and a positive return on equity of 6.17%. The business had revenue of $288.20 million for the quarter, compared to analysts’ expectations of $297.61 million. During the same period last year, the business earned $0.50 earnings per share. The company’s quarterly revenue was down 8.5% on a year-over-year basis.

Several research firms recently commented on VSI. Zacks Investment Research raised Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 18th. BidaskClub cut Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. Deutsche Bank AG reaffirmed a “hold” rating and set a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Morgan Stanley set a $8.00 price objective on Vitamin Shoppe and gave the company a “hold” rating in a research report on Thursday, August 10th. Finally, Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and set a $6.00 price objective (down from $13.00) on shares of Vitamin Shoppe in a research report on Thursday, August 10th. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. Vitamin Shoppe currently has a consensus rating of “Hold” and an average target price of $5.00.

In other news, Director John D. Bowlin bought 40,000 shares of the stock in a transaction on Friday, August 25th. The shares were bought at an average price of $5.50 per share, with a total value of $220,000.00. Following the completion of the acquisition, the director now owns 56,028 shares in the company, valued at $308,154. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.07% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Arizona State Retirement System lifted its holdings in Vitamin Shoppe by 0.8% in the second quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock valued at $145,000 after acquiring an additional 100 shares during the period. Texas Permanent School Fund lifted its holdings in Vitamin Shoppe by 0.8% in the second quarter. Texas Permanent School Fund now owns 17,389 shares of the specialty retailer’s stock valued at $203,000 after acquiring an additional 145 shares during the period. BNP Paribas Arbitrage SA lifted its holdings in Vitamin Shoppe by 2.1% in the second quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after acquiring an additional 192 shares during the period. Capstone Asset Management Co. lifted its holdings in Vitamin Shoppe by 3.5% in the second quarter. Capstone Asset Management Co. now owns 14,040 shares of the specialty retailer’s stock valued at $164,000 after acquiring an additional 470 shares during the period. Finally, Credit Suisse AG lifted its holdings in Vitamin Shoppe by 1.2% in the first quarter. Credit Suisse AG now owns 72,256 shares of the specialty retailer’s stock valued at $1,456,000 after acquiring an additional 863 shares during the period. 98.39% of the stock is currently owned by institutional investors.

The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.34 and a current ratio of 2.07. The company has a market capitalization of $83.92, a price-to-earnings ratio of 3.71 and a beta of 0.74.

ILLEGAL ACTIVITY NOTICE: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.watchlistnews.com/vitamin-shoppe-inc-vsi-shares-gap-down-on-disappointing-earnings/1694648.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.